Environmental Impacts on COVID-19: Mechanisms of Increased Susceptibility
References
- Sly PD, Trottier BA, Bulka CM, Cormier SA, Fobil J, Fry RC, et al. The interplay between environmental exposures and COVID-19 risks in the health of children. Environmental Health. 2021; 20(1): 34. DOI: 10.1186/s12940-021-00716-z
- Zhu Y, Chew KY, Wu M, Karawita AC, McCallum G, Steele LE, et al. Ancestral SARS-CoV-2, but not Omicron, replicates less efficiently in primary pediatric nasal epithelial cells. PLos Biology. 2022; In press. DOI: 10.1371/journal.pbio.3001728
- Belay ED, Godfred-Cato S. SARS-CoV-2 spread and hospitalisations in paediatric patients during the omicron surge. Lancet Child Adolesc Health. 2022; 6(5): 280–1. DOI: 10.1016/S2352-4642(22)00060-8
- Goldizen FC, Sly PD, Knibbs LD. Respiratory effects of air pollution on children. Pediatr Pulmonol. 2015; 51: 94–108. DOI: 10.1002/ppul.23262
- Stern G, Latzin P, Roosli M, Fuchs O, Proietti E, Kuehni C, et al. A prospective study of the impact of air pollution on respiratory symptoms and infections in infants. Am J Respir Crit Care Med. 2013; 187(12): 1341–8. DOI: 10.1164/rccm.201211-2008OC
- Cui Y, Zhang Z-F, Froines J, Zhao J, Wang H, Yu S-Z, et al. Air pollution and case fatality of SARS in the People’s Republic of China: an ecologic study. Environmental Health. 2003; 2(1): 15. DOI: 10.1186/1476-069X-2-15
- Wu X, Nethery RC, Sabath MB, Braun D, Dominici F. Air pollution and COVID-19 mortality in the United States: Strengths and limitations of an ecological regression analysis. Science Advances. 2020; 6(45):
eabd4049 . DOI: 10.1126/sciadv.abd4049 - Sly PD, Trottier B, Ikeda-Araki A, Vilcins D. Environmental impacts on infectious disease: a literature view of epidemiological evidence. Annals of Global Health. 2022; In Press.
- Gloster J, Alexandersen S. New directions: Airborne transmission of foot-and-mouth disease virus. Atmospheric Environment. 2004; 38(3): 503–5. DOI: 10.1016/j.atmosenv.2003.10.014
- Sedlmaier N, Hoppenheidt K, Krist H, Lehmann S, Lang H, Buttner M. Generation of avian influenza virus (AIV) contaminated fecal fine particulate matter (PM2.5): Genome and infectivity detection and calculation of immission. Veterinary Microbiology. 2009; 139(1–2): 156–64. DOI: 10.1016/j.vetmic.2009.05.005
- Setti L, Passarini F, De Gennaro G, Barbieri P, Perrone MG, Borelli M, et al. SARS-Cov-2RNA found on particulate matter of Bergamo in Northern Italy: First evidence. Environmental Research. 2020; 188. DOI: 10.1016/j.envres.2020.109754
- Liu L, Wang P, Nair MS, Yu J, Rapp M, Wang Q, et al. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. Nature. 2020; 584(7821): 450–6. DOI: 10.1038/s41586-020-2571-7
- Pivato A, Amoruso I, Formenton G, Di Maria F, Bonato T, Vanin S, et al. Evaluating the presence of SARS-CoV-2 RNA in the particulate matters during the peak of COVID-19 in Padua, northern Italy. Science of The Total Environment. 2021; 784: 147129. DOI: 10.1016/j.scitotenv.2021.147129
- Kennedy IM. The health effects of combustion-generated aerosols. Proceedings of the Combustion Institute. 2007; 31: 2757–70. DOI: 10.1016/j.proci.2006.08.116
- Cass GR, Hughes LA, Bhave P, Kleeman MJ, Allen JO, Salmon LG. The chemical composition of atmospheric ultrafine particles. Philosophical Transactions of the Royal Society a-Mathematical Physical and Engineering Sciences. 2000; 358(1775): 2581–92. DOI: 10.1098/rsta.2000.0670
- Jaligama S, Saravia J, You D, Yadav N, Lee GI, Shrestha B, et al. Regulatory T cells and IL10 suppress pulmonary host defense during early-life exposure to radical containing combustion derived ultrafine particulate matter. Respir Res. 2017; 18(1): 15. DOI: 10.1186/s12931-016-0487-4
- Lee GI, Saravia J, You D, Shrestha B, Jaligama S, Hebert VY, et al. Exposure to combustion generated environmentally persistent free radicals enhances severity of influenza virus infection. Part Fibre Toxicol. 2014; 11: 57. DOI: 10.1186/s12989-014-0057-1
- Saravia J, Lee GI, Lomnicki S, Dellinger B, Cormier SA. Particulate matter containing environmentally persistent free radicals and adverse infant respiratory health effects: a review. J Biochem Mol Toxicol. 2013; 27(1): 56–68. DOI: 10.1002/jbt.21465
- Harvey WT, Carabelli AM, Jackson B, Gupta RK, Thomson EC, Harrison EM, et al. SARS-CoV-2 variants, spike mutations and immune escape. Nature Reviews Microbiology. 2021; 19(7): 409–24. DOI: 10.1038/s41579-021-00573-0
- Meng B, Kemp SA, Papa G, Datir R, Ferreira IATM, Marelli S, et al. Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7. Cell Reports. 2021; 35(13): 109292. DOI: 10.1016/j.celrep.2021.109292
- McCallum M, De Marco A, Lempp FA, Tortorici MA, Pinto D, Walls AC, et al. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell. 2021; 184(9): 2332–47.e16. DOI: 10.1016/j.cell.2021.03.028
- Elezkurtaj S, Greuel S, Ihlow J, Michaelis EG, Bischoff P, Kunze CA, et al. Causes of death and comorbidities in hospitalized patients with COVID-19. Scientific Reports. 2021; 11(1): 4263. DOI: 10.1038/s41598-021-82862-5
- Chi X, Yan R, Zhang J, Zhang G, Zhang Y, Hao M, et al. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2. Science. 2020; 369(6504): 650–5. DOI: 10.1126/science.abc6952
- Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020; 146(1): 110–8. DOI: 10.1016/j.jaci.2020.04.006
- Shepley-McTaggart A, Sagum CA, Oliva I, Rybakovsky E, DiGuilio K, Liang J, et al. SARS-CoV-2 Envelope (E) protein interacts with PDZ-domain-2 of host tight junction protein ZO1. PLOS ONE. 2021; 16(6):
e0251955 . DOI: 10.1371/journal.pone.0251955 - Camini FC, da Silva Caetano CC, Almeida LT, de Brito Magalhães CL. Implications of oxidative stress on viral pathogenesis. Arch Virol. 2017; 162(4): 907–17. DOI: 10.1007/s00705-016-3187-y
- Boukhenouna S, Wilson MA, Bahmed K, Kosmider B. Reactive Oxygen Species in Chronic Obstructive Pulmonary Disease. Oxid Med Cell Longev. 2018; 2018: 5730395. DOI: 10.1155/2018/5730395
- Chang R, Mamun A, Dominic A, Le NT. SARS-CoV-2 Mediated Endothelial Dysfunction: The Potential Role of Chronic Oxidative Stress. Front Physiol. 2020; 11: 605908. DOI: 10.3389/fphys.2020.605908
- Harmon AC, Hebert VY, Cormier SA, Subramanian B, Reed JR, Backes WL, et al. Particulate matter containing environmentally persistent free radicals induces AhR-dependent cytokine and reactive oxygen species production in human bronchial epithelial cells. PLoS One. 2018; 13(10):
e0205412 . DOI: 10.1371/journal.pone.0205412 - Iwasaki A, Foxman EF, Molony RD. Early local immune defences in the respiratory tract. Nat Rev Immunol. 2017; 17(1): 7–20. DOI: 10.1038/nri.2016.117
- Chen H, Liu W, Wang Y, Liu D, Zhao L, Yu J. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients. EBioMedicine. 2021; 70: 103500. DOI: 10.1016/j.ebiom.2021.103500
- Henderson LA, Canna SW, Schulert GS, Volpi S, Lee PY, Kernan KF, et al. On the Alert for Cytokine Storm: Immunopathology in COVID-19. Arthritis Rheumatol. 2020; 72(7): 1059–63. DOI: 10.1002/art.41285
- Karki R, Sharma BR, Tuladhar S, Williams EP, Zalduondo L, Samir P, et al. Synergism of TNF-alpha and IFN-gamma Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes. Cell. 2021; 184(1): 149–68 e17. DOI: 10.1016/j.cell.2020.11.025
- Shimizu M.
Clinical Features of Cytokine Storm Syndrome . In: Cron RQ, Behrens EM (eds.), Cytokine Storm Syndrome. Cham: Springer International Publishing. 2019; 31–41. DOI: 10.1007/978-3-030-22094-5_3 - Alamdari DH, Moghaddam AB, Amini S, Keramati MR, Zarmehri AM, Alamdari AH, et al. Application of methylene blue -vitamin C -N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial. Eur J Pharmacol. 2020; 885: 173494. DOI: 10.1016/j.ejphar.2020.173494
- Mrityunjaya M, Pavithra V, Neelam R, Janhavi P, Halami PM, Ravindra PV. Immune-Boosting, Antioxidant and Anti-inflammatory Food Supplements Targeting Pathogenesis of COVID-19. Front Immunol. 2020; 11: 570122. DOI: 10.3389/fimmu.2020.570122
- Beigmohammadi MT, Bitarafan S, Hoseindokht A, Abdollahi A, Amoozadeh L, Mahmoodi Ali Abadi M, et al. Impact of vitamins A, B, C, D, and E supplementation on improvement and mortality rate in ICU patients with coronavirus-19: a structured summary of a study protocol for a randomized controlled trial. Trials. 2020; 21(1): 614. DOI: 10.1186/s13063-020-04547-0
- de Alencar JCG, Moreira CL, Müller AD, Chaves CE, Fukuhara MA, da Silva EA, et al. Double-blind, Randomized, Placebo-controlled Trial With N-acetylcysteine for Treatment of Severe Acute Respiratory Syndrome Caused by Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2021; 72(11): e736–e41.
DOI: https://doi.org/10.5334/aogh.3907 | Journal eISSN: 2214-9996
Language: English
Submitted on: Jul 15, 2022
Accepted on: Sep 28, 2022
Published on: Oct 21, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2022 Stephania A Cormier, Ayaho Yamamoto, Kirsty R. Short, Luan Vu, William A Suk, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.